Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,007.57, with a market capitalization of 950.5B. The stock trades at a price-to-earnings (P/E) ratio of 44.35 and offers a dividend yield of 61.2%.
As of 2026-03-03, Eli Lilly(LLY) stock has fluctuated between $995.07 and $1,019.97. The current price stands at $1,007.57, placing the stock +1.3% above today's low and -1.2% off the high.
Eli Lilly(LLY) shares are trading with a volume of 1.55M, against a daily average of 3.18M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study, officially titled “A Study to Investigate the Safety, Tolerability,...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study A Phase 1, Participant- and Investigator-Blind, Placebo-Controlled,...
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
Analyst ratings
79%
of 34 ratingsMore LLY News
Eli Lilly (NYSE:LLY) and Scribe Therapeutics reached a key milestone in their collaboration to develop in vivo CRISPR-based genetic medicines targeting neurolog...
When you think "top-performing pharma stock," Eli Lilly may first come to mind. Yet while Lilly's shares have surged over the past few years, they've only gaine...
Key Points Eli Lilly's ongoing innovations could set the business up for a long time. The company also has a strong dividend program. 10 stocks we like bette...
Novo Nordisk (NVO 0.37%) stock has been a trainwreck of late. In just the past 12 months, the Danish healthcare stock has lost around 60% of its value. Things h...
Finally! You can open a SoFi Crypto account and access 25 plus cryptocurrencies without juggling apps or logins. This post may contain links from our sponsors...
Key Points Eli Lilly is the current leader in the GLP-1 weight-loss drug space. Investors have placed a high valuation on Lilly's stock. Pfizer could be a mo...
Eli Lilly (LLY) is back in focus after fresh clinical data showed its injectable GLP-1 drug tirzepatide and oral candidate orforglipron outperforming Novo Nordi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.